Kenneth Crawford

Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5

Konstantinos J. Mavrakis, E. Robert McDonald, Michael R. Schlabach et al. · Science · 2016 · 538 citations

Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer

Matthew T. Burger, Sabina Pecchi, Allan S. Wagman et al. · ACS Medicinal Chemistry Letters · 2011 · 248 citations · Full text

2,4-Bismorpholino 6-Heterocyclic Pyrimidines, Pi3 Kinase Inhibitor, Orally Bioavailable Class +18

Terfenadine metabolism in human liver. In vitro inhibition by macrolide antibiotics and azole antifungals.

Mallé Jurima‐Romet, Kenneth Crawford, Terry D. Cyr et al. · Drug Metabolism and Disposition · 1994 · 162 citations

Several Convenient Methods for the Synthesis of 2-Amido Substituted Furans

Albert Padwa, Kenneth Crawford, Paitoon Rashatasakhon et al. · The Journal of Organic Chemistry · 2003 · 92 citations

LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 84 citations · Full text